logo

For the Inventor, By the Inventor

Hayward, CA, United States of America

Aradigm Corporation


USPTO Granted Patents = 130



Trademarks = 3

Forward Citations = 9,727

Loading Chart...
Loading Chart...

42 inventors (with patents filed for the assignee):

goldMedal Reid M Rubsamen (67 out of 74 patents)

silverMedal Igor Gonda (44 out of 54 patents)

bronzeMedal Jeffrey A Schuster (30 out of 43 patents)

4.  Lester John Lloyd (23 out of 46 patents)

5.  Stephen J Farr (20 out of 31 patents)

6.  Peter M Lloyd (17 out of 18 patents)

7.  David C Cipolla (16 out of 21 patents)

8.  James Blanchard (13 out of 15 patents)

9.  Sudarsan Srinivasan (12 out of 12 patents)

10.  Rajesh S Patel (12 out of 28 patents)

11.  Eric T Johansson (10 out of 26 patents)

12.  Carl Ritson (8 out of 29 patents)

13.  Christopher J Flaim (6 out of 8 patents)

14.  David E Goodman (5 out of 16 patents)

15.  Thor Miller Wilbanks (3 out of 5 patents)


Core Competencies:
Inhalable Formulations
Liposomal Formulations
Ciprofloxacin
Aerosol Drug Delivery
Tobacco Cessation
Insulin Delivery
Nanocrystals
Gastrointestinal Diagnostics
Pulmonary Delivery
Temperature Control Devices
Erectile Dysfunction Treatment
Non-Destructive Analysis

130 patents:

1. 10420765 - Concentrated, inhalable ciprofloxacin formulation (2019-09-24),
2. 10376508 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria (2019-08-13),
3. 9987227 - Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile (2018-06-05),
4. 9968555 - Liposomal formulations that form drug nanocrystals after freeze-thaw (2018-05-15),
5. 9857387 - Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals (2018-01-02),
6. 9844548 - Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals (2017-12-19),
7. 9592220 - Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract (2017-03-14),
8. 9545401 - Concentrated, inhalable ciprofloxacin formulation (2017-01-17),
9. 9532986 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria (2017-01-03),
10. 9511199 - Pore structures for reduced pressure aerosolization (2016-12-06),
11. 9457006 - Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract (2016-10-04),
12. 9421185 - Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract (2016-08-23),
13. 9372198 - Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals (2016-06-21),
14. 9259424 - Concentrated, inhalable antibiotic formulation (2016-02-16),
15. 9078897 - Concentrated, inhalable antibiotic formulation (2015-07-14),
Aradigm Corporation is a specialty pharmaceutical company focused on the development and commercialization of innovative drugs for the treatment of severe respiratory diseases. They are dedicated to improving patient outcomes by offering unique therapeutic solutions. Visit their website to learn more about their products and initiatives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
130 Patents

#1 in Hayward, CA

#660 in California

#2,855 in US

#5,994 in the World

...
Hayward, CA, United States of America

Aradigm Corporation

Forward Citations = 9,727

42 inventors:

goldMedal Reid M Rubsamen (67 out of 74 patents)

silverMedal Igor Gonda (44 out of 54 patents)

bronzeMedal Jeffrey A Schuster (30 out of 43 patents)

4.  Lester John Lloyd (23 out of 46 patents)

5.  Stephen J Farr (20 out of 31 patents)

Please report any incorrect information to support@idiyas.com
Loading…